C16:0 CERAMIDE (D18:2(4E 8Z)/16:0)

Code: 860692P-1MG D2-231

Not available outside of the UK & Ireland.

Biochem/physiol Actions

C16:0-ceramide facilitates obesity-related insulin resistance. It exhibits pro-apoptotic function. Elevated levels of C16:0-ceramide has been observed...


 Read more

Your Price
$429.44 1MG
REQUEST

Not available outside of the UK & Ireland.

Biochem/physiol Actions

C16:0-ceramide facilitates obesity-related insulin resistance. It exhibits pro-apoptotic function. Elevated levels of C16:0-ceramide has been observed in adipose tissue of obese patients.

General description

C16:0 Ceramide (d18:2(4E,8Z)/16:0) or N-palmitoyl-D-erythro-sphingosine (d18:2(4E,8Z) base) is a long chain ceramide derived from sphingosine containing two double bonds with palmitic acid. C16:0 Ceramide synthesis is catalyzed by the enzyme ceramide synthase 6 (CerS6).

Packaging

5 mL Amber Glass Screw Cap Vial (860692P-1mg)

formpowder
manufacturer/tradenameAvanti Polar Lipids 860692P
packagingpkg of 1 × 1 mg (860692P-1mg)
shipped indry ice
SMILES stringOC[C@@](NC(CCCCCCCCCCCCCCC)=O)([H])[C@]([H])(O)/C=C/CC/C=CCCCCCCCCC
storage temp.−20°C
Cas Number1919028-96-8
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.